Novartis’ Managing Director of Oncology (ANZ/NZ) joins Medlab Clinical board
DATE: Tuesday 23rd March 2021
The managing director of Novartis Oncology for Australia and New Zealand, Cheryl Maley, has been appointed to the board of Medlab Clinical as a Non-Executive Director. Mrs Maley joins the board with strong pharmaceutical experience including over 20 years in roles across Sales, Marketing, Business Development, Commercial Excellence, Patient Access and General Management.
Mrs Maley is a knowledgeable and multi-functional leader with a proven track record in accelerating and driving long-term strategic growth through innovation, partnering and steering organisational development and projects. Cheryl’s global focus, especially within her US (Chicago-based for three years) and Asia tenure (Philippines-based for three years) in seeing products through to regulatory approval and knowledge of the oncology market, will be invaluable as we embark on the next stage of our journey.
Read about our market release available at BiotechDispatch.
Learn more about our Leadership team here.
About the author
Medlab in-house Editor.